Lenzilumab
Product Specifications
CAS Number
1229575-09-0
Target
C-Fms, SARS-CoV
Related Pathways
Microbiology/Virology, Tyrosine Kinase/Adaptors
Purity
0.989
Bioactivity
Lenzilumab (KB 003) is a humanized granulocyte-macrophage colony-stimulating factor (GM-CSF) neutralizing antibody that directly binds to GM-CSF and prevents signaling through its receptor, and can be used to study COVID-19.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC042796-100 1x 100 µL
Desmoglein-3 (Squamous Cell Marker) (DSG3/2796), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details ![11-(Chloroacetyl)-5,11-dihydro-6H-pyrido[2,3-b][1,4]benzodiazepin-6-one](https://cdn.genprice.uk/products/572/8913500186305/imageurl/trc-c363405-2g.webp)
TRC-C363405-2G 2 g
11-(Chloroacetyl)-5,11-dihydro-6H-pyrido[2,3-b][1,4]benzodiazepin-6-one
Sign In for Pricing
View Details 
BNC942340-500 1x 500 µL
Tyrosinase-Related Protein-1 (TYRP-1) (Melanoma Marker) (TYRP1/2340R), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details ![FITC Anti-Mouse CD326/EpCAM Antibody[G8.8]](https://cdn.genprice.uk/products/763/68dd1495061270361e7cd72f/imageurl/e-ab-f1181uc.webp)